sprite-preloader
Anzeige
Mehr »
Sonntag, 17.02.2019 Börsentäglich über 12.000 News von 595 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von IPO Home

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
SaBlackstone-backed Alight files for an estimated $750 million IPO
FrStealth BioTherapeutics prices IPO at $12, the low end of the range
FrHoth Therapeutics prices IPO at $5.60, the low end of the range
FrBlackstone-backed Alight files for an estimated $600 million IPO
DoAvedro prices IPO at $14, the low end of the range
DoEarly stage cancer biotech TCR2 Therapeutics prices IPO at $15 midpoint
DoCannabis blank check Tuscan Holdings files for a $200 million IPO
MiLevi Strauss has filed to go public; will #IPO on NYSE under the ticker $LEVI
MiE-sports platform Super League Gaming sets terms for $25 million IPO
MiSlack isn't the only company to pick a direct listing over an IPO
DiMicro-cap biotech Anchiano Therapeutics prices IPO at $11.50, below the expected price
DiHennessy Capital Acquisition IV files for a $250 million IPO
DiMicro-cap BankFlorida postpones $42 million IPO
09.02.US IPO Weekly Recap: Two billion-dollar biotechs cap a mixed week for biotech IPOs
09.02.Arch Capital-backed insurer Watford Holdings schedules direct listing
08.02.Gossamer Bio prices upsized IPO at $16
08.02.Micro-cap CRM software provider Verb Technology sets terms for $20 million IPO
07.02.Dementia and Alzheimer's biotech Alector prices IPO at $19, the midpoint of the range
07.02.Energy SPAC Tortoise Acquisition files for a $225 million IPO
06.02.Mitochondrial dysfunction biotech Stealth BioTherapeutics sets terms for $81 million IPO
06.02.Micro-cap coal producer American Resources files for a $9 million Nasdaq IPO
06.02.China-focused SPAC Wealthbridge Acquisition prices $50 million IPO at $10
05.02.Immuno-oncology biotech TCR2 Therapeutics sets terms for $75 million IPO
05.02.2 billion-dollar biotechs will IPO this week; here's how the last 5 performed
04.02.Ophthalmic medical device maker Avedro sets terms for $75 million IPO